Psychiatry · Bridgeton, MO
NPI
1578562310
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
12255 de Paul Dr Ste 490
Bridgeton, MO, 63044
Phone (314) 344-7770
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
881 services
Medicare patients, 2024
206
Average age 64
Drug cost, 2024
$1.8M
7,572 prescriptions
Company payments, 2025
$2,301
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by M.Javed Qasim was code 99213 (office e&m - established), 414 times for 145 patients. In total M.Javed Qasim billed 881 services in 11 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 414 | 145 | $52.01 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 274 | 46 | $60.15 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 55 | 29 | $90.33 | $4,968 |
| 99238 Hospital Discharge Management | Facility | 31 | 30 | $61.75 | $1,914 |
| 99223 Hospital E&M - Initial | Facility | 29 | 28 | $132.00 | $3,828 |
| 90833 Psychotherapy - Nongroup | Office | 24 | 14 | $42.45 | $1,019 |
| 99214 Office E&M - Established | Office | 24 | 19 | $80.25 | $1,926 |
By year: 2022 $69K for 1,126 services; 2023 $60K for 941 services; 2024 $54K for 881 services.
Medicare prescription drug claims, 2024
In 2024, the drug M.Javed Qasim prescribed most often to Medicare patients was Alprazolam, with 519 prescriptions and refills. In total M.Javed Qasim wrote 7,572 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 519 | 559 | 71 | $2,122 |
| Quetiapine Fumarate Generic | 377 | 565 | 86 | $7,171 |
| Clonazepam Generic | 370 | 421 | 60 | $2,511 |
| Trazodone Hcl Generic | 356 | 512 | 122 | $2,483 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 312 | 321 | 39 | $6,537 |
| Lorazepam Generic | 308 | 328 | 57 | $1,404 |
| Duloxetine Hcl Generic | 275 | 388 | 72 | $5,324 |
| Buspirone Hcl Generic | 245 | 362 | 68 | $3,218 |
| Zolpidem Tartrate Generic | 232 | 258 | 36 | $1,878 |
| Escitalopram Oxalate Generic | 192 | 310 | 53 | $1,502 |
| Sertraline Hcl Generic | 171 | 263 | 46 | $931 |
| Divalproex Sodium Generic | 170 | 239 | 36 | $4,251 |
| Lamotrigine Generic | 167 | 300 | 47 | $2,969 |
| Mirtazapine Generic | 143 | 193 | 32 | $2,715 |
| Olanzapine Generic | 142 | 172 | 33 | $2,699 |
Brand drugs: 739 claims; generic drugs: 6,833 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid M.Javed Qasim $2,301 ($2,301 in general payments such as food, travel and fees) from 14 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $541.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 25 | $541 |
| Neurocrine BioSciences, Inc. NBIX | 19 | $421 |
| Alkermes, Inc. ALKS | 12 | $267 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 16 | $264 |
| Abbvie Inc. ABBV | 7 | $191 |
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $191 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $153 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $98.59 |
| Bausch Health US, LLC BHC | 2 | $48.65 |
| Lundbeck LLC | 2 | $44.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.